Last reviewed · How we verify
The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.
This is a Phase 1, open-label, fixed-sequence, 3-period, 2-way drug interaction study designed to assess the PK, PD, safety, and tolerability of LC350189 and colchicine when administered alone and in combination in healthy subjects.
Details
| Lead sponsor | LG Chem |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 24 |
| Start date | Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Gout
- Hyperuricemia
Interventions
- Xanthine Oxidase Inhibitor
Countries
United States